During the past decade, Gastro One conducted 86 clinical trials. In the 10-year time frame, 86 clinical trials started and 71 clinical trials were completed, i.e. on average, 82.6% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 46 clinical trials were completed. i.e. 219% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gastro One" #1 sponsor was "Gilead Sciences" with 29 trials, followed by "Shire" with 11 trials sponsored, "Bristol-Myers Squibb" with 10 trials sponsored, "Exact Sciences Corporation" with 9 trials sponsored and "Celgene" with 9 trials sponsored. Other sponsors include 82 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gastro One" #1 collaborator was "Gilead Sciences" with 4 trials as a collaborator, "Galapagos NV" with 3 trials as a collaborator, "RTI Health Solutions" with 2 trials as a collaborator, "Athersys, Inc" with 1 trials as a collaborator and "Cedars-Sinai Medical Center" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Gastro One" are "Crohn's Disease" (27 trials), "Ulcerative Colitis" (22 trials), "Colorectal Cancer" (9 trials), "Nonalcoholic Steatohepatitis" (9 trials) and "Hepatitis C, Chronic" (8 trials). Many other conditions were trialed in "Gastro One" in a lesser frequency.

Most popular intervention types in "Gastro One" are "Drug" (132 trials), "Other" (15 trials), "Biological" (9 trials), "Device" (4 trials) and "Diagnostic Test" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (55 trials), "RBV" (8 trials), "Ribavirin" (8 trials), "Filgotinib" (7 trials) and "Sofosbuvir" (5 trials). Other intervention names were less common.

The vast majority of trials in "Gastro One" are 150 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Gastro One". undefined are not yet recruiting, 9 are recruiting, 18 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 98 completed trials in Gastro One, undefined suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Gastro One, 2 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 73 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Gastro One has several departments that took part in Clinical trials: "Gastro One - Germantown Office - Wolf Park Drive" - 3 trials